newsfilter
← Earnings
Earnings Releases·

Inogen — Third Quarter 2026 Earnings Summary

  • Financial metrics for the period ended September 30, 2026, are not disclosed in this release and will be announced separately.
  • The company is executing a divestiture of Rotech to streamline its commercial model, with plans to classify the Rental Business as discontinued operations.
  • Leadership transitioned to Andy Reding as President and CEO, who previously served as COO and led the Rotech transaction.
  • Management anticipates a shift toward sustainable, profitable growth and expanded access to respiratory solutions, though specific guidance on revenue, margins, or share repurchase amounts is not provided.
  • The company will host a conference call at 5:00 p.m. ET to discuss third-quarter results and the impact of the Rotech transaction.
Company
INOGEN INC
Sector
Healthcare
Industry
Medical Devices